Stephen F. Carter

Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by ¹¹ C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining ¹¹ C-Pittsburgh Compound B and ¹⁸ F-FDG

Stephen F. Carter, Michael Schöll, Ove Almkvist et al. · Journal of Nuclear Medicine · 2012 · 435 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

Elena Rodriguez‐Vieitez, Laure Saint‐Aubert, Stephen F. Carter et al. · Brain · 2016 · 306 citations · Full text

Medicine, Neurology, Neuroscience +17

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Annapaola Prestia, Anna Caroli, Wiesje M. van der Flier et al. · Neurology · 2013 · 189 citations

Medicine, Neurology, Neuroscience +17

A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease

Agneta Nordberg, Stephen F. Carter, Juha O. Rinne et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 185 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography

Michael Schöll, Stephen F. Carter, Eric Westman et al. · Scientific Reports · 2015 · 146 citations · Full text

Medicine, Neurology, Neuroscience +17